MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma (Q39385197)

11 September 2017

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma (English)

1 reference

11 September 2017

2

1 reference

11 September 2017

11

1 reference

11 September 2017

K Boll

1

1 reference

11 September 2017

K Kasack

3

1 reference

11 September 2017

N Mörbt

4

1 reference

11 September 2017

A K Kretzschmar

5

1 reference

11 September 2017

J M Tomm

6

1 reference

11 September 2017

G Verhaegh

7

1 reference

11 September 2017

J Schalken

8

1 reference

11 September 2017

M von Bergen

9

1 reference

11 September 2017

F Horn

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

5 March 2012

1 reference

11 September 2017

1 reference

11 September 2017

32

1 reference

11 September 2017

3

1 reference

11 September 2017

277-285

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.55

11 September 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

The power and promise of "rewiring" the mitogen-activated protein kinase network in prostate cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

MicroRNAs and cancer--new paradigms in molecular oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Widespread deregulation of microRNA expression in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Towards the definition of prostate cancer-related microRNAs: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Identification of human microRNA targets from isolated argonaute protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

ARA24/Ran enhances the androgen-dependent NH2- and COOH-terminal interaction of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Paths of FGFR-driven tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

The new human kallikrein gene family: implications in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Ras signaling in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

miR 488* inhibits androgen receptor expression in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

MicroRNAs associated with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Tat-binding protein-1 (TBP-1), an ATPase of 19S regulatory particles of the 26S proteasome, enhances androgen receptor function in cooperation with TBP-1-interacting protein/Hop2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Circulating microRNAs, potential biomarkers for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Evolution of the androgen receptor pathway during progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Using GOstats to test gene lists for GO term association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

miRecords: an integrated resource for microRNA-target interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

MicroRNAs and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.55

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.55

1 reference

11 September 2017

1 reference